Correlation Between Vaxart and EnGene Holdings
Can any of the company-specific risk be diversified away by investing in both Vaxart and EnGene Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxart and EnGene Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaxart Inc and enGene Holdings Common, you can compare the effects of market volatilities on Vaxart and EnGene Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxart with a short position of EnGene Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxart and EnGene Holdings.
Diversification Opportunities for Vaxart and EnGene Holdings
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Vaxart and EnGene is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Vaxart Inc and enGene Holdings Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on enGene Holdings Common and Vaxart is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxart Inc are associated (or correlated) with EnGene Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of enGene Holdings Common has no effect on the direction of Vaxart i.e., Vaxart and EnGene Holdings go up and down completely randomly.
Pair Corralation between Vaxart and EnGene Holdings
Given the investment horizon of 90 days Vaxart Inc is expected to under-perform the EnGene Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Vaxart Inc is 1.34 times less risky than EnGene Holdings. The stock trades about -0.15 of its potential returns per unit of risk. The enGene Holdings Common is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 661.00 in enGene Holdings Common on September 4, 2024 and sell it today you would earn a total of 208.00 from holding enGene Holdings Common or generate 31.47% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 98.46% |
Values | Daily Returns |
Vaxart Inc vs. enGene Holdings Common
Performance |
Timeline |
Vaxart Inc |
enGene Holdings Common |
Vaxart and EnGene Holdings Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vaxart and EnGene Holdings
The main advantage of trading using opposite Vaxart and EnGene Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxart position performs unexpectedly, EnGene Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnGene Holdings will offset losses from the drop in EnGene Holdings' long position.The idea behind Vaxart Inc and enGene Holdings Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.EnGene Holdings vs. Agilent Technologies | ||
EnGene Holdings vs. Equillium | ||
EnGene Holdings vs. 23Andme Holding Co | ||
EnGene Holdings vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |